NCT05321095Completed
Screening for Albuminuria at the First Line for Early Identification of CKD
Screening for Albuminuria at the First Line for Early Identification of Chronic Kidney Disease: a Pilot Study
Source: ClinicalTrials.gov · Last updated 9 Aug 2024
Brief summary (registry, in English)
Early detection of kidney disease
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 141 (actual)
- First submitted
- 7 Feb 2022
- Start date
- 25 Nov 2021
- Primary completion date
- 31 Dec 2023
- Lead sponsor
- General Practitioners Research Institute
- Diseases
- Chronic kidney disease
- NCT number
- NCT05321095
What you commit to
- Study type: Observational
- Participants enrolled: 141
- From 25 Nov 2021 to the primary completion date, 31 Dec 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Inability to understand and sign the informed consent form
- Pregnancy
Who the study is looking for
- Diabetes Mellitus (diagnosis or prescription for the disease based on the NHG guidelines)
- Adipositas (diagnosis)
- Hypertension (diagnosis or prescription for the disease based on the NHG guidelines)
- Cardiovascular disease (diagnosis, specified in protocol section 5.2.2)
- Lipid disorder (diagnosis or prescription for the disease based on the NHG guidelines)
Age in the registry: 18 years to 80 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| General Practitioners Research Institute Coordinator of this site? Confirm its status | Groningen | Netherlands | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.